Australian Alkaloids Trading (AAT) is a 100% Australian-owned API manufacturer specializing in naturally extracted alkaloid APIs and semi-synthetic compounds derived from Duboisia plants. AAT is a joint venture of Phytex and Australian Alkaloids, with 60+ years of combined experience. The company controls its entire supply chain domestically in Australia, from Duboisia plantations through extraction, purification, and final API release. Products include scopolamine (hyoscine) derivatives, atropine derivatives, and methscopolamine bromide. AAT's facilities are cGMP licensed with the TGA, USFDA inspected, and supply USP and PMRJ reference standards. They have a history of zero product recalls.
alkaloid API extraction, Duboisia plant cultivation, scopolamine/atropine derivatives, vertically integrated botanical API supply chain, semi-synthesis of niche alkaloid derivatives
1 site worldwide
No reviews available yet.
No documents available.